Åke Öhrlund

Title: Innovations by Åke Öhrlund: A Focus on Injectable Gel Products

Introduction

Åke Öhrlund, an accomplished inventor based in Uppsala, Sweden, has made significant contributions to the field of biomedical innovations. With a total of six patents to his name, Åke has focused on developing advanced gel products that have the potential to enhance medical applications. His work in creating injectable gel products has opened new avenues in therapies requiring deliverable formulations.

Latest Patents

Among his notable patents, Åke introduced a groundbreaking method of producing an injectable gel product. This method involves cross-linking a first glycosaminoglycan (GAG) with a crosslinking agent under specific conditions to create a gel. The unique process ensures a delicate balance in the charging ratio of the crosslinking agent to disaccharide units, maintaining it below 0.15. Additional steps include preparing particles of the gel, mixing with a second GAG, and obtaining injectable particles that contain multiple cross-linked GAG gel particles of the inner phase.

Another significant patent is centered on manufacturing a shaped cross-linked hyaluronic acid product. This method entails a single cross-linking reaction of a non-cross-linked precipitated hyaluronic acid substrate shaped in a liquid medium with a pH of 11.5 or higher. The innovative approach allows for the creation of a precipitated, shaped cross-linked hyaluronic acid product, providing a degree of modification that supports greater functionality in medical applications.

Career Highlights

Åke Öhrlund has had a noteworthy career in the biotechnology sector, primarily with companies such as Galderma Holding SA and Galderma Holdings SA. His experience in these organizations has allowed him to refine his expertise in the development of innovative gel products, equipping him for future endeavors in the field of biomedicine.

Collaborations

Throughout his career, Åke has had the opportunity to work alongside skilled professionals like Morgan Karlsson and Anne Helander Kenne. These collaborations have likely fostered an environment of creativity and innovation, further propelling Åke's research and development of pioneering products.

Conclusion

In summary, Åke Öhrlund's contributions to injectable gel products underscore the impact of innovative thinking in the biomedical field. His patents reflect a commitment to enhancing medical therapies through cutting-edge technology. Future advancements from Åke and his collaborations promise to continue shaping the landscape of biomedical innovations.